| Editorial (thematic issue:“miRNA and cancer; computational and experimental approaches”) Y Tutar Current pharmaceutical biotechnology 15 (5), 429-429, 2014 | 266 | 2014 |
| Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety İ Koca, A Özgür, KA Coşkun, Y Tutar Bioorganic & medicinal chemistry 21 (13), 3859-3865, 2013 | 221 | 2013 |
| Pseudogenes Y Tutar International Journal of Genomics 2012 (1), 424526, 2012 | 191 | 2012 |
| Heat shock proteins; an overview L Tutar, Y Tutar Current Pharmaceutical Biotechnology 11 (2), 216-222, 2010 | 182 | 2010 |
| Role for Hsp70 Chaperone in Saccharomyces cerevisiae Prion Seed Replication Y Song, Y Wu, G Jung, Y Tutar, E Eisenberg, LE Greene, DC Masison Eukaryotic cell 4 (2), 289-297, 2005 | 137 | 2005 |
| The role of cysteine cathepsins in cancer progression and drug resistance M Rudzińska, A Parodi, SM Soond, AZ Vinarov, DO Korolev, AO Morozov, ... International journal of molecular sciences 20 (14), 3602, 2019 | 104 | 2019 |
| Isolation and identification of free‐living amoebae from tap water in Sivas, Turkey KA Coşkun, S Özçelik, L Tutar, N Elaldı, Y Tutar BioMed research international 2013 (1), 675145, 2013 | 97 | 2013 |
| MicroRNAs and cancer; an overview L Tutar, E Tutar, Y Tutar Current pharmaceutical biotechnology 15 (5), 430-437, 2014 | 95 | 2014 |
| Primate Chaperones Hsc70 (Constitutive) and Hsp70 (Induced) Differ Functionally in Supporting Growth and Prion Propagation in Saccharomyces cerevisiae Y Tutar, Y Song, DC Masison Genetics 172 (2), 851-861, 2006 | 91 | 2006 |
| Therapeutic targeting of microRNAs in cancer: future perspectives L Tutar, E Tutar, A Özgür, Y Tutar Drug development research 76 (7), 382-388, 2015 | 80 | 2015 |
| Involvement of miRNAs and pseudogenes in cancer L Tutar, A Özgür, Y Tutar MicroRNA and Cancer: Methods and Protocols, 45-66, 2018 | 75 | 2018 |
| A comparison of piezosurgery and conventional surgery by heat shock protein 70 expression Y Gülnahar, HH Köşger, Y Tutar International journal of oral and maxillofacial surgery 42 (4), 508-510, 2013 | 57 | 2013 |
| Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis İ Koca, A Özgür, M Er, M Gümüş, KA Coşkun, Y Tutar European journal of medicinal chemistry 122, 280-290, 2016 | 55 | 2016 |
| Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers F Acibucu, HS Dökmetaş, Y Tutar, Ş Elagoz, F Kilicli Experimental and Clinical Endocrinology & Diabetes 122 (03), 137-143, 2014 | 54 | 2014 |
| CO-releasing properties and anticancer activities of manganese complexes with imidazole/benzimidazole ligands E Üstün, A Özgür, KA Coşkun, S Demir, İ Özdemir, Y Tutar Journal of Coordination Chemistry 69 (22), 3384-3394, 2016 | 53 | 2016 |
| A novel approach to inhibit heat shock response as anticancer strategy by coumarine compounds containing thiazole skeleton İ Koca, M Gumus, A Ozgur, A Disli, Y Tutar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 39 | 2015 |
| Anticancer activities of manganese-based photoactivatable CO-releasing complexes (PhotoCORMs) with benzimidazole derivative ligands E Üstün, A Özgür, KA Coşkun, S Demir Düşünceli, İ Özdemir, Y Tutar Transition Metal Chemistry 42, 331-337, 2017 | 37 | 2017 |
| Heat shock protein 90 inhibitors in oncology A Ozgur, Y Tutar Current Proteomics 11 (1), 2-16, 2014 | 37 | 2014 |
| Role of protein aggregation in neurodegenerative diseases Y Tutar, A Özgür, L Tutar, Y Tutar, A Özgür, L Tutar Neurodegenerative Diseases, 55-76, 2013 | 36 | 2013 |
| Heat shock protein 90 inhibition in cancer drug discovery: from chemistry to futural clinical applications Y Tutar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 32 | 2016 |
Lütfi TUTARAssistant Professor, Molecular Biology and Genetics , Ahi Evran University在 ahievran.edu.tr 的电子邮件经过验证
